Home › Funds › Sofinnova Investments, Inc. › EWTX

Sofinnova Investments, Inc. position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Sofinnova Investments, Inc. reported holding 380,923 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$15.5M, representing 0.82% of its reported portfolio and ranking #32 among its reported holdings. Sofinnova Investments, Inc. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)380.92K sh
Reported value held$15.48M
Portfolio Weight0.82%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s EWTX position evolved

Sofinnova Investments, Inc. first disclosed a stake in EWTX in Q2 2024 at 475,691 shares (US$8.6M). The position peaked in Q2 2026 at 380,923 shares, worth US$15.5M. Across 9 filings, Sofinnova Investments, Inc. increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 380,923 shares valued at US$15.5M — a reduction of -5,575 shares quarter over quarter.. Notable position changes include a 124% increase in Q2 2025 (shares rose 24% over the following quarter), a 27% trim in Q3 2025 (shares rose 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 475.69K $8.57M New
Q3 2024 384.77K $10.27M Reduce
Q4 2024 402.77K $10.75M Add
Q1 2025 320.40K $7.05M Reduce
Q2 2025 716.87K $9.40M Add
Q3 2025 520.24K $8.44M Reduce
Q4 2025 437.82K $10.86M Reduce
Q1 2026 386.50K $12.17M Reduce
Q2 2026 380.92K $15.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Sofinnova Investments, Inc. held EWTX?

Sofinnova Investments, Inc. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Sofinnova Investments, Inc.'s current position in EWTX?

As of Q2 2026, Sofinnova Investments, Inc. holds 380.92K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $15.48M, representing 0.82% of its reported portfolio and ranking #32.

Has Sofinnova Investments, Inc. been buying or selling EWTX?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. reduced its position in EWTX. The position peaked in Q2 2026 at 380.92K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.